share_log

Champions Oncology Q1 EPS $(0.02) Misses $0.01 Estimate, Sales $13.74M Beat $13.19M Estimate

Champions Oncology Q1 EPS $(0.02) Misses $0.01 Estimate, Sales $13.74M Beat $13.19M Estimate

冠軍腫瘤學第一季度每股收益0.02美元低於預期0.01美元,銷售額1374萬美元超過預期1319萬美元
Benzinga Real-time News ·  2022/09/08 16:02

Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.01 by 300 percent. This is a 300 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $13.74 million which beat the analyst consensus estimate of $13.19 million by 4.21 percent. This is a 22.15 percent increase over sales of $11.25 million the same period last year.

冠軍腫瘤公司(納斯達克股票代碼:CSBR)公佈季度虧損為每股0.02美元,低於分析師一致預期的0.01美元,跌幅為300%。這比去年同期每股0.01美元的收益下降了300%。該公司公佈的季度銷售額為1374萬美元,比分析師普遍預期的1319萬美元高出4.21%。這比去年同期1125萬美元的銷售額增長了22.15%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論